Ilmocin Gola Dolore (Ketoprofen Lysine)

Ketoprofen lysine blocks the activity of cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which reduces the production of prostaglandins. Lower prostaglandin levels diminish inflammation, pain signalling, and fever, providing analgesic and anti‑inflammatory effects at the site of application.

The appropriate dose is determined by the prescribing healthcare professional based on the individual’s condition, age, weight, and overall health. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for ketoprofen lysine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both ketoprofen lysine and ibuprofen belong to the NSAID class and share similar mechanisms of COX inhibition. Ketoprofen lysine often provides a slightly stronger anti‑inflammatory effect at equivalent doses, but individual response and tolerability can vary, so the choice depends on clinical judgment.

Store the product at ambient temperature below 25 °C, in its original packaging, protected from moisture and direct sunlight. Do not expose it to excessive heat or humidity, and keep it out of reach of children.

The medication is applied directly to the oral mucosa, typically by placing the tablet or lozenge in the mouth and allowing it to dissolve slowly. It should be used as directed by a healthcare professional, without chewing or swallowing whole if the formulation requires dissolution.

Serious risks include gastrointestinal ulceration or bleeding, severe skin reactions such as Stevens‑Johnson syndrome, acute renal impairment, and life‑threatening allergic reactions like anaphylaxis. Patients should seek immediate medical attention if they experience symptoms such as severe abdominal pain, rash, swelling, or difficulty breathing.

Individuals with known hypersensitivity to ketoprofen, other NSAIDs, or any component of the formulation should avoid it. It is also contraindicated in patients with active gastrointestinal bleeding, severe renal or hepatic impairment, and those who have experienced severe asthma attacks triggered by NSAIDs.